Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.02 EUR | +1.04% |
|
-.--% | -.--% |
06-20 | SWISS REINSURANCE COMPANY : Buy rating from JP Morgan | ZD |
06-13 | Carbonfuture, Swiss Re Sign 70,000 MT Biochar Offtake Deal --OPIS | DJ |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 8.57 for the current year.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Weaknesses
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Reinsurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 36.51B | - | ||
+31.89% | 8.53B | - | ||
+0.47% | 5.9B | - | - | |
-2.27% | 4.94B | B | ||
+10.49% | 837M | C- | ||
+14.75% | 654M | - | - | |
+17.86% | 546M | - | - | |
+79.51% | 364M | B- | ||
+18.67% | 174M | - | - | |
+9.18% | 155M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SREN Stock
- SR9 Stock
- Ratings Swiss Re Ltd